These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2840110)

  • 21. Erythrocyte pyrimidine-5'-nucleotidase activity as a sensitive indicator of lead exposure.
    Torrance JD; Mills W; Kilroe-Smith TA; Smith AN
    S Afr Med J; 1985 May; 67(21):850-2. PubMed ID: 2986302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Erythrocyte nucleotides in lead workers.
    Ichiba M; Tomokuni K; Mori K
    Int Arch Occup Environ Health; 1992; 63(6):419-21. PubMed ID: 1544691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of lead exposure in workers at secondary lead smelters in South Korea: with focus on activity of erythrocyte pyrimidine 5'-nucleotidase (P5N).
    Kim Y; Lee H; Lee CR; Park DU; Yang JS; Park IJ; Lee KY; Lee M; Kim TK; Sohn NS; Cho YS; Lee N; Chung HK
    Sci Total Environ; 2002 Mar; 286(1-3):181-9. PubMed ID: 11886093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of lead chelation therapy with EDTA in children on erythrocyte pyrimidine 5'-nucleotidase and with cytidine triphosphate levels.
    Swanson MS; Angle CR; Stohs SJ
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):497-500. PubMed ID: 6293983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chicken erythrocyte pyrimidine 5'-nucleotidase: purification and characterization of the subclass I enzyme.
    Hokari S; Miyazaki T; Hasegawa M; Koyama L; Komoda T
    Biol Chem; 2001 Jun; 382(6):919-24. PubMed ID: 11501756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A role of red cell pyrimidine 5'-nucleotidase in experimental lead poisoning.
    Fujii H
    Arch Toxicol; 1979 Oct; 43(1):59-64. PubMed ID: 231420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro effects of lead, mercury and cadmium on the enzymic activity of red-blood cell pyrimidine 5'-nucleotidase.
    Mohammed-Brahim B; Buchet JP; Bernard A; Lauwerys R
    Toxicol Lett; 1984 Feb; 20(2):195-9. PubMed ID: 6320500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Erythrocyte nucleotides from control and lead-treated rabbits.
    Swanson MS; Angle CR; Stohs SJ; Rovang KS
    Res Commun Chem Pathol Pharmacol; 1980 Feb; 27(2):353-61. PubMed ID: 6245437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accumulation of erythrocyte nucleotides and their pattern in lead workers.
    Sakai T; Araki T; Ushio K
    Arch Environ Health; 1990; 45(5):273-7. PubMed ID: 2256711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of pyrimidine 5'nucleotidase activity in erythrocytes of sheep, dogs, cats, horses, calves, and Mongolian gerbils.
    George JW; Duncan JR; Mahaffey EA
    Am J Vet Res; 1983 Oct; 44(10):1968-70. PubMed ID: 6314858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relation between reticulocyte count and characteristics of erythrocyte 5'-nucleotidase in dogs, cats, cattle and humans.
    Hossain MA; Yamato O; Yamasaki M; Otsuka Y; Maede Y
    J Vet Med Sci; 2003 Feb; 65(2):193-7. PubMed ID: 12655113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of pyrimidine 5'-nucleotidase subclass I during erythrocyte maturation in rats.
    Hokari S; Miyazaki T; Matsunaga T; Koyama I; Hasegawa M; Komoda T
    J Hematother Stem Cell Res; 2001 Oct; 10(5):703-7. PubMed ID: 11672517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Normal pyrimidine 5'-nucleotidase activity level of Japanese subjects and a significance as a marker for low concentration of lead in blood (author's transl)].
    Sato Y; Sasaki T; Taniguchi N; Saito K
    Nihon Eiseigaku Zasshi; 1981 Jun; 36(2):518-25. PubMed ID: 6273619
    [No Abstract]   [Full Text] [Related]  

  • 34. The in vitro effect of 13 metals on the activity of erythrocyte pyrimidine 5'-nucleotidase (P5N).
    Oishi H; Ichiba M; Tomokuni K
    J Toxicol Sci; 1994 Nov; 19(4):197-201. PubMed ID: 7884830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case of lead intoxication: clinical and biochemical studies.
    Miwa S; Ishida Y; Takegawa S; Urata G; Toyoda T
    Am J Hematol; 1981; 11(1):99-105. PubMed ID: 6267939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of lead exposure on some biological indices related to porphyrin metabolism and the activity of erythrocyte pyrimidine 5'-nucleotidase in the mice.
    Tomokuni K; Ichiba M; Hirai Y
    Arch Toxicol; 1989; 63(1):23-8. PubMed ID: 2545181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics of red cell pyruvate kinase (PK) and pyrimidine 5'nucleotidase (P5N) abnormalities in acute leukaemia and chronic lymphoid diseases with leukaemic expression.
    Vives Corrons JL; Pujades MA; Sierra J; Ribera JM
    Br J Haematol; 1987 Jun; 66(2):173-7. PubMed ID: 3038159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of concanavalin A on 5'-nucleotidase activity of rabbit blood platelets.
    Nishio H; Takeshita K; Okugawa K; Segawa T
    Jpn J Pharmacol; 1987 Feb; 43(2):230-3. PubMed ID: 3033367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deficiency of pyrimidine 5'-nucleotidase in human leukocytes.
    de Korte D; van Doorn CC; Sijstermans JM; van Gennip AH; Roos D
    J Inherit Metab Dis; 1989; 12(3):267-72. PubMed ID: 2559246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Three families with hereditary hemolytic anemia and pyrimidine 5'-nucleotidase deficiency: electrophoretic and kinetic studies.
    Hirono A; Fujii H; Miyajima H; Kawakatsu T; Hiyoshi Y; Miwa S
    Clin Chim Acta; 1983 May; 130(2):189-97. PubMed ID: 6307548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.